Tushar Manudhane
Stock Analyst at Motilal Oswal
(3.47)
# 2,335
Out of 4,835 analysts
5
Total ratings
100%
Success rate
47.9%
Average return
Main Sectors:
Stocks Rated by Tushar Manudhane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Reiterated: Hold | n/a | $1,358.90 | - | 2 | Jul 24, 2026 | |
| NSE: RUBICON Rubicon Research Limited | Reiterated: Buy | ₹955.00 → ₹1,160 | ₹1,790 | -35.20% | 2 | May 30, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹2,640 | ₹2,256 | +17.00% | 1 | Apr 29, 2026 |
Cipla Limited
Jul 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,358.90
Upside: -
Rubicon Research Limited
May 30, 2026
Reiterated: Buy
Price Target: ₹955.00 → ₹1,160
Current: ₹1,790
Upside: -35.20%
Mankind Pharma Limited
Apr 29, 2026
Reiterated: Buy
Price Target: ₹2,640
Current: ₹2,256
Upside: +17.00%